Related by context. All words. (Click for frequent words.) 62 Janus Kinase 61 selectively binds 61 Kinase Inhibitor 60 CG# [001] 60 PDE4 inhibitor 60 mTOR inhibitor 60 murine monoclonal antibody 59 liposomal formulation 59 generation purine nucleoside 59 Aurora Kinase 59 PN# [001] 59 PRLX # 59 investigational humanized monoclonal antibody 59 DB# [003] 58 PI3K inhibitor 58 Daclizumab 58 humanized monoclonal 58 PRO# [003] 58 RAV# 58 EP# [003] 58 Xanafide 58 PEGylated interferon 58 targeted radiotherapeutic 57 AKT inhibitor 57 Archexin 57 orally dosed 57 non nucleoside 57 somatostatin analogue 57 APiX 57 TG# [001] 57 Tyrosine Kinase Inhibitor 57 CDK inhibitor 57 non nucleoside inhibitor 57 Guanilib 57 p# inhibitor 57 TLK# 57 Chemokine Receptor 57 selective agonist 57 TKB# 57 novel immunotherapeutic 57 Receptor Agonist 57 Novolimus 56 SYN# 56 TRC# 56 MU# [002] 56 oral prodrug 56 volociximab 56 vidofludimus 56 Zybrestat 56 mertansine 56 DEB# 56 fosbretabulin 56 Onconase 56 Tezampanel 56 AEG# 56 PEG IFN 56 antisense inhibitor 56 orally administered inhibitor 56 CYT# potent vascular disrupting 56 hyaluronidase enzyme 56 small molecule Hedgehog 56 miRview mets 56 polycythemia vera PV 56 rxRNA 56 QuadraSphere 56 targeted antifolate 56 JAK2 inhibitor 56 Enzastaurin 56 Dapagliflozin 56 immunotoxin 56 acute peripheral arterial 56 EP# [005] 56 tiapamil 56 replicon 56 IMC #B 55 EGFR HER2 55 Liposomal 55 RhuDex ® 55 histone deacetylase inhibitor 55 PEGylated Fab fragment 55 HepaSphere 55 THR beta agonist 55 Oral Insulin 55 LHRH antagonists 55 SensoLyte ® 55 antibody MAb 55 TRX1 55 ACUROX ® 55 Personalized Immunotherapy 55 humanized monoclonal antibody 55 Small Molecule 55 M#V 55 receptor tyrosine kinase inhibitor 55 UV Visible 55 SAR# [002] 55 IAP inhibitors 55 Omacetaxine 55 Panzem R NCD 55 potently inhibit 55 pharmacodynamic PD 55 IIIc 55 polymerase inhibitor 55 peripherally acting 55 novel synthetic peptide 55 MT#/MEDI-# 55 ARRY # 55 radiolabeled 55 MORAb 55 ribavirin Copegus ® 55 Aptamer 55 Qdot 55 Aplidin 55 ESBA# 55 novel prodrug 55 recombinant adeno associated 55 Factor VIIa 55 Hemodiafiltration 55 HSP# inhibitor 55 Orally administered 55 Agilent #B [002] 55 BrachySil TM 55 preclinical efficacy 55 BAL# [002] 55 PF# [002] 55 virus AAV 55 Epirubicin 55 Phase 2b Clinical Trial 54 vascular disrupting agent 54 GW# [003] 54 diarrhea predominant irritable 54 PF # [001] 54 HDAC Inhibitor 54 LB# [003] 54 Monoclonal Antibody 54 MEK inhibitor 54 PSN# [002] 54 Investigational Oral 54 vapreotide acetate 54 TG# [003] 54 small molecule glucokinase 54 lexidronam injection 54 Preclinical studies suggest 54 Pafuramidine 54 lysates 54 metastatic malignant 54 TG# [004] 54 defensin mimetic antibiotic 54 highly selective inhibitor 54 ONX 54 SCH # 54 TH# [003] 54 Completes Patient Enrollment 54 Iluvien ® 54 MKC# 54 cytotoxic conjugate 54 Soliris eculizumab 54 Sudhir Agrawal D.Phil 54 AS# amonafide L malate 54 XL# [003] 54 oral proteasome inhibitor 54 Degarelix 54 Receptor Antagonist 54 Sitrans 54 Angiocept 54 Files IND 54 Dose Ranging Study 54 intranasal formulation 54 selective adenosine 54 Receptor Antagonists 54 LX# [003] 54 Silodosin 54 Gleevec resistant 54 IAP inhibitor 54 Illumina Solexa 54 pain palliation 54 HGS# 54 ChronVac C R 54 HDACi 54 Tarvacin 54 rusalatide acetate 54 EML4 ALK 54 Oligonucleotide 54 PARI Pharma GmbH 54 PPMO 54 IL# PE#QQR 54 Safinamide 54 Phase Ib II 54 selective antagonist 54 Octreotide 54 Polymer Microspheres 54 PrevOnco 54 HuMax 54 TMC# [002] 53 COBAS R 53 anticancer compound 53 PF # [002] 53 Posiphen 53 Aptocine 53 Vicriviroc 53 BEMA TM Fentanyl 53 GORE TAG Device 53 histone deacetylase HDAC inhibitor 53 fludarabine phosphate 53 orally inhaled 53 IMA# 53 CD# monoclonal antibody 53 JAK1 53 Darusentan 53 novel oral anticoagulant 53 CD# CEA 53 Hsp# Inhibitor 53 adenosine injection 53 DuNE 53 paclitaxel Taxol 53 opioid receptor antagonist 53 Tasimelteon 53 Ganciclovir 53 anti CD3 monoclonal 53 topically applied SEPA 53 assisted laser desorption 53 oral nucleoside analogue 53 AK# [003] 53 DUROS 53 RNAi Therapeutic 53 Phase 2a Clinical Trial 53 MKC# MKC# PP 53 RH1 53 MEK inhibitors 53 Phenotyping 53 Receives Orphan Drug Designation 53 cannabinor 53 XL# anticancer compounds 53 proprietary polysaccharide 53 Alocrest 53 aurora kinase 53 triciribine phosphate monohydrate 53 humanized anti 53 PNP inhibitor 53 QRT PCR 53 RNAi therapeutic targeting 53 pentamidine 53 FVIIa 53 Bortezomib 53 plasmid DNA vaccine 53 FOLOTYN ® 53 Trofex 53 Panzem R 53 Aurora kinase inhibitor 53 Myocardial Perfusion Imaging 53 treat benign prostatic 53 Clinical Trial Results 53 XL# XL# 53 reslizumab 53 Methylnaltrexone 53 small molecule tyrosine 53 oral antiviral 53 epothilone 53 catheter occlusion 53 RTL# 53 MoxDuo ® 53 Deadlinepix 53 Intravesical 53 Cannabinor 53 gemcitabine Gemzar ® 53 HCl Injection 53 hypoxia activated prodrug 53 ALN TTR 53 CORT # 53 ZP# [002] 53 Vicinium TM 53 EndoTAG TM -1 53 PEG SN# 53 tumor vascular disrupting 53 Vilazodone 53 Dynabeads 53 huN# DM1 53 novel orally administered 53 SELDI 53 Sanvar R 53 aldehyde dehydrogenase ALDH2 deficiency 53 bevacizumab Avastin R 52 Epothilone 52 CX# CX# [001] 52 Ambrisentan 52 G#A [001] 52 Cavity Ring Down 52 immunotherapeutic agent 52 Anidulafungin 52 ATPace TM 52 Dalbavancin 52 allogeneic cell 52 antibody MT# 52 Hemopurifier ® 52 bispecific 52 developing Bicifadine serotonin 52 DG# [003] 52 T#M 52 SoftScan ® 52 fluticasone furoate 52 Hedgehog pathway inhibitor 52 HCV polymerase 52 ATL# [001] 52 PD LID 52 EOquin TM 52 VitiGam 52 Forodesine 52 ZOLINZA 52 Taqman 52 AQ4N 52 triple quadrupole mass spectrometer 52 ND# [002] 52 XTEN 52 Ion Trap 52 E1 INT TM 52 acting neuraminidase inhibitor 52 Bicifadine 52 Dx 52 QPCR 52 TLR8 agonist 52 PEGPH# 52 VentiRx Pharmaceuticals 52 sterile lidocaine patch 52 Annamycin 52 SW# [003] 52 Fx #A 52 Iluvien TM 52 microplate reader 52 phage display library 52 prokinetic agent 52 Phase Ib clinical 52 cetuximab Erbitux ® 52 HuMax CD4 52 CINtec ® PLUS 52 C#A [002] 52 Drug Candidate 52 immunomodulatory therapy 52 OncoVEX GM CSF 52 CEQ# 52 fusion inhibitor 52 Ophthotech 52 Bremelanotide 52 CodeLink 52 pharmacokinetic PK study 52 Maribavir 52 Panzem 52 OXIGON 52 plasmid encoding 52 lucinactant 52 INT# [002] 52 Deferiprone 52 Western Blotting 52 IND Application 52 Neovascularization 52 NRTI resistance 52 Kissei Pharmaceutical 52 sulodexide 52 FOLFOX6 52 biotinylated 52 PSN# [001] 52 patented Bioral 52 CCR5 antagonist 52 Phase IIb clinical trials 52 Phase IIa trials 52 CD3 monoclonal antibody 52 xenograft model 52 5 HT3 antagonist 52 phosphorothioate 52 NS5B 52 inhaled formulation 52 Aerosurf 52 Phase 2b clinical trials 52 AxSYM 52 PrevOnco ™ 52 Onalta ™ 52 ficlatuzumab 52 ATL/TV# 52 HCV protease inhibitor 52 paclitaxel poliglumex 52 Curaxin 52 ALN HPN 52 MVA HPV IL2 52 triphendiol 52 antisense drug 52 ^ sup #m 52 AFREZZA TM 52 GLP toxicology studies 52 XL# XL# XL# 52 Spiegelmer ® 52 refractory prostate cancer 52 Initiates Phase II 52 ocular formulation 52 OvaRex R 52 MB# MB# 52 Alferon N 52 FDA Approvals 52 clade B 52 Traficet EN 52 virus HCV protease inhibitor 52 Resten NG 52 Microwave Ablation System 51 Abbokinase 51 Vaprisol 51 IB# [002] 51 NanoTab 51 omega interferon 51 biliary tract cancer 51 DirectFET R 51 ALN PCS 51 ATL# [002] 51 II Clinical Trial 51 Phase Ib clinical trials 51 P#X# antagonist 51 Kuvan sapropterin dihydrochloride 51 IND enabling 51 TBC# 51 KSP inhibitor 51 novel orally bioavailable 51 Cloretazine ® 51 NeoLipid R 51 Adrenergic 51 LymphoStat B TM 51 Ciclesonide 51 Phase Ib study 51 mGluR5 negative 51 ISENTRESS raltegravir 51 chemiluminescence 51 Ecallantide 51 Photodynamic 51 Bosutinib 51 Pivotal Phase III 51 seliciclib CYC# 51 Initiate Phase 51 Enkephalin 51 Cetuximab Erbitux 51 HCV polymerase inhibitor 51 PDX pralatrexate 51 Meets Primary Endpoint 51 zileuton 51 LHRH antagonist 51 Phase #b/#a clinical 51 haematologic 51 arginine vasopressin AVP 51 NADiA 51 drug eluting coronary stent 51 pharmacokinetic PK 51 Kevetrin 51 Phase #b/#a trial 51 novel histone deacetylase 51 Vinorelbine 51 Anticalin 51 Ceflatonin R 51 Ceflatonin 51 BrachySil ™ 51 Phase 1a clinical 51 DermTech International 51 DEV DA TOMAR NEXT 51 Syllego system 51 AlphaScreen 51 TELINTRA 51 PI3K/Akt pathway inhibitor 51 DU# [002] 51 VISICOL R 51 XYOTAX TM 51 essential thrombocythemia ET 51 rxRNA ™ compounds 51 Commences Phase 51 Phase 2a Trial 51 ARIKACE ™ 51 Capesaris 51 molecular imaging radiopharmaceutical 51 Aposense 51 Achieves Primary Endpoint 51 elotuzumab 51 registrational trial 51 Prodarsan ® 51 Phase 2b Trial 51 sublingual formulation 51 wilate ® 51 dasatinib Sprycel ® 51 ToF SIMS 51 Investigational eFlow Nebulizer System 51 Tumor Targeting 51 FT# [001] 51 V# V# [001] 51 IN.PACT Falcon 51 photodiode array 51 TOF TOF 51 ADP receptor antagonist 51 Xyfid TM 51 Maleate 51 Pharmacokinetics PK 51 ultrasensitive detection 51 Initiated Phase 51 p# biomarker 51 Electronic Brachytherapy System 51 investigational HCV polymerase 51 Melphalan 51 GLPG# 51 Amrubicin 51 MT# MEDI 51 JAK inhibitor 51 Illumina Infinium 51 F. tularensis 51 Phase 2b Study 51 Roflumilast 51 Azedra 51 solifenacin succinate 51 Flexar 50 phase Ib clinical 50 AMPAKINE CX# 50 BioFlux 50 Investigational eFlow 50 ME# [002] 50 chemotherapeutic drug 50 Surfactant Replacement Therapy 50 BN# [002] 50 Cefazolin 50 circadian cytokine modulator 50 mu opioid receptor antagonist 50 Phase IIb Trial 50 concurrent chemoradiation 50 DPP4 inhibitor 50 Ultratrace 50 Ala Ala 50 Alvesco R 50 OMNARIS Nasal Spray 50 site directed mutagenesis 50 vinorelbine tartrate 50 VisuMax 50 selective androgen receptor modulator 50 Anavex #-# 50 pioglitazone HCl 50 Transdermal Patch 50 Augment TM 50 IIa trials 50 Celgosivir 50 Serdaxin 50 Pivotal Phase 50 amaZon 50 Nimotuzumab 50 OncoVEX 50 AzaSite Plus 50 FP# [003] 50 cromolyn sodium 50 Teysuno 50 next generation URAT1 50 BRILINTA 50 Discovery Labs aerosolized 50 VEGF inhibitor 50 ALVESCO ® 50 Gets FDA Clearance 50 including eniluracil ADH 50 VisEn Medical 50 AAG geldanamycin analog 50 kinase profiling 50 pro brain natriuretic 50 Hepatitis C HCV 50 immunotherapeutic vaccine 50 Initiate Clinical Trial 50 AV2 50 IGF 1R inhibitor 50 Nucleic Acid Test 50 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 50 BeadXpress 50 Sequencers 50 TO AVOID PREGNANCY WHILE 50 novel emulsion formulation 50 Civacir 50 HYLENEX recombinant 50 Familial Adenomatous Polyposis FAP 50 Caliper LabChip 50 Bioanalyzer 50 transthyretin TTR mediated amyloidosis 50 topical gel formulation 50 vemurafenib 50 JZP 50 CCR9 antagonist 50 SQiDworks 50 T1D 50 S#F [001] 50 Clevudine 50 Anturol TM 50 Field Effect Transistor 50 brand ciclesonide HFA 50 subcutaneously administered 50 Glucophage R 50 Phase IIb Clinical Trial 50 subcutaneous formulation 50 hPTH #-# 50 Therapeutic Vaccine 50 GSK# [002] 50 QTOF 50 absorption enhancer 50 AERx R 50 amikacin 50 EOquin 50 electrosurgical generator 50 Novel Antibody 50 Diabetic Neuropathy 50 Dabigatran etexilate 50 PHASE III 50 Antibody Drug Conjugate 50 EXPAREL TM 50 Transdermal Delivery 50 covalently bound 50 initiated Phase Ib 50 Aeroquin 50 Soft Tissue Sarcoma 50 ONCONASE R 50 VAPRISOL 50 Serostim ® 50 Phase IIb trials 50 Phase IIa Clinical Trial 50 Autosampler 50 HIV integrase inhibitor 50 MALDI TOF 50 BRIM2 50 investigational pan BCR 50 phase IIa 50 estrogen receptor antagonist 50 phase IIb trial 50 IPLEX 50 Phase III Clinical Trial 50 Zenpep 50 SinuNase ™ 50 T#C [003] 50 ATS Simulus R 50 granisetron formulated 50 beta 1a 50 Medoxomil 50 #DF [001] 50 Simulect 50 SEPET TM 50 Luveniq 50 D#A [002] 50 phase IIb clinical 50 fluoropyrimidine 50 AV# [001] 50 bronchoscopic 50 occlusion PAO 50 RELOVAIR ™ 50 SPD# 50 Lauriad 50 novel nucleoside analog 50 mineralocorticoid 50 Junovan TM 50 PET tracers 50 TKM ApoB 50 somatostatin analog 50 AnaSpec Introduces 50 nasal spray formulation 50 RT PCR assay 50 Fodosine 49 inhalation powder 49 Ozarelix 49 Signal Generator 49 Mg Usa 49 ACUROX 49 product candidate Lpathomab 49 Files Investigational 49 Immunoassay System 49 Protein Kinase 49 enhanced laser desorption 49 sd rxRNA 49 Embolic Protection System 49 CytoSorb 49 Dynaflow TM 49 PAM4 49 VERSANT 49 Nucleotide 49 #I [003] 49 Nucleic Acids Res 49 subcutaneous implant 49 PGLA 49 abacavir Ziagen 49 Cloretazine R 49 GEMS TM 49 CB2 selective receptor agonist 49 TOF MS 49 non nucleoside HCV 49 Troxatyl TM 49 PROMUS Element 49 PEP# [003] 49 torezolid 49 Nebulizer System 49 AMD# [002] 49 NAVISTAR R 49 ^ Tc 49 Affymetrix GeneChip 49 TriActiv R 49 ABL inhibitor 49 RhuDex TM 49 severe gastroparesis 49 INCB# [001] 49 BIO SET 49 Successfully Completes Phase 49 DNA Methylation 49 investigational immunotherapy 49 NOX E# 49 lentiviral vector 49 clade C 49 benign prostatic hypertrophy BPH 49 PATHFINDER ® 49 gets USFDA nod 49 NADiA ProsVue 49 CytoFabTM 49 randomized controlled Phase 49 Florbetapir 49 transduced 49 Davanat 49 amifampridine phosphate 49 Levoleucovorin 49 DNA Polymerase 49 mechanical thrombectomy 49 ghrelin antagonist 49 pharmacokinetics PK 49 Bioral R 49 Linear Array 49 ALN TTR# 49 diabetic neuropathic pain 49 gonadotropin releasing hormone GnRH 49 selective A2A adenosine receptor 49 SPRYCEL ® 49 Nucleic Acid 49 glycopeptide 49 interstitial cystitis painful 49 ImmuKnow R 49 ACTOS ® 49 Orazol 49 inhaled iloprost 49 ORE# 49 QuantiGene 49 Loxapine 49 phase IIa clinical 49 NM# [001] 49 EVIZON TM 49 IND submission 49 DF# [003] 49 Spectrometers 49 MALDI TOF TOF 49 midstage trials 49 Dual Opioid 49 tunable filter 49 hematology analyzers 49 phase Ib 49 Troxatyl 49 viral nucleic acids 49 AFRS TM 49 ST8 49 GLAST Burst Monitor 49 Ultra Compact 49 phase IIb study 49 Oral Spray 49 HoFH 49 miconazole Lauriad ® 49 histamine dihydrochloride 49 adecatumumab MT# 49 zanolimumab 49 either acutely decompensated 49 Actemra tocilizumab 49 Balaglitazone 49 renal artery stenting 49 Virtex 5 49 Telatinib 49 pan histone deacetylase 49 miconazole Lauriad 49 electro-optical/infrared 49 TR FRET 49 Signal Analyzer 49 Successfully Demonstrated 49 Printheads 49 Phase IIB 49 microcatheters 49 Pharmaceuticals Initiates 49 #G SFP + 49 PathVysion 49 glucosidase 49 LUMINATE 49 Tumor Response 49 VentiRx 49 CTO recanalization 49 Phase IIa trial 49 Vascular Disrupting Agent 49 EGS# 49 aerosol formulation 49 ALTROPANE R 49 long acting muscarinic 49 fallopian tube cancers 49 include Phenoptin TM 49 STARFlex 49 olmesartan medoxomil hydrochlorothiazide 49 urethral bulking agent 49 Siemens Simatic 49 aminolevulinic acid ALA 49 NH# [002] 49 Phase III Pivotal 49 PROGENSA R 49 GORE VIABAHN ® 49 Initiates Clinical Trials 49 Serial Analyzer 49 inhibitor PPI 49 Valortim TM 49 R#/MEM # 49 AERx iDMS 48 LE SN# 48 symptomatic paroxysmal AF 48 tartrate Inhalation Solution 48 WaveScan 48 Phase Ib 48 UPLYSO 48 amrubicin 48 ELISA assay 48 WP# [002] 48 Terbinafine 48 ProteinChip 48 BEMA Granisetron 48 PR# [003] 48 Lamotrigine 48 oral ridaforolimus 48 Demonstrates Potential 48 receptor agonists 48 multiplexed assays 48 Imatinib mesylate 48 GeneChip ® 48 Prefilled Syringe 48 orally disintegrating 48 KE# [001] 48 Dacogen decitabine 48 Laquinimod 48 ER# [003] 48 Confocal microscopy 48 Adjunctive 48 tomography PET 48 ILUVIEN ® 48 Loramyc R 48 metformin XR 48 carboxypeptidase 48 Chlamydia trachomatis CT 48 Phase #b/#a 48 Perflubutane Polymer Microspheres 48 Icatibant 48 Galantamine 48 mitogen activated ERK kinase 48 SmartChip System 48 Infusion System 48 Tissue Matrix 48 therapeutic antibody 48 mGluR2 positive 48 KinomeScan 48 CRMD# 48 bardoxolone 48 prucalopride 48 optically coupled 48 C#S 48 NUVIGIL ® 48 TaqMan R 48 topical anti infective 48 maturation inhibitor 48 Trofile assay 48 QRX 48 Sequence Capture 48 Preclinical studies 48 dorzolamide 48 Differential Pressure 48 Atmospheric Pressure 48 GLP1 INT TM 48 pharmacological chaperone 48 NuroPro PD 48 #F FDG 48 ALGRX 48 inhibitor VX 48 nonclinical studies 48 trastuzumab DM1 T DM1 48 Kreatech 48 Mass Spectrometer 48 FDA APPROVES 48 LatticeECP DSP 48 acyclovir Lauriad R 48 DURIN TM 48 Helixate R 48 Fentanyl TAIFUN R 48 recurrent glioblastoma 48 cutaneous T 48 Augment ™ 48 sphingomyelin 48 AX# [001] 48 Dural Sealant 48 investigational antiplatelet 48 prasterone 48 measuring #.#mm x [001] 48 SYNAPT G2 48 DURECT proprietary 48 Talotrexin 48 NET# [002] 48 aerosolized KL4 surfactant 48 SNP Genotyping 48 Inhaled AAT 48 Electroporation 48 ZYBRESTAT TM 48 Miconazole 48 PNT# 48 ALVESCO R 48 nizatidine 48 Embolic Protection 48 Interferometric 48 assay kits 48 Affymetrix GeneChip ® 48 Fluidigm BioMark 48 transfection reagent 48 PLK1 SNALP 48 XOMA 3AB 48 Cepheid Xpert 48 Ofloxacin 48 #G XFP 48 Phased Array 48 Phase #/#a trial 48 transurethral 48 SG# [002] 48 dextromethorphan quinidine 48 SpliceArray 48 MoxDuo 48 TACAN 48 GALNS 48 visilizumab 48 Verigene System 48 QLT# 48 omacetaxine mepesuccinate 48 BLA filing 48 PROVENGE sipuleucel T 48 potent CYP#A# inhibitors 48 PRTX 48 PET Scanner 48 Dynamic Light Scattering 48 Fibrin Sealant 48 peripheral arterial occlusive disease 48 perifosine KRX 48 Zolpimist ™ 48 Natalizumab 48 Biochip 48 Pilocarpine 48 PROMACTA ® 48 clonidine hydrochloride 48 Labeling Kit 48 tramiprosate Alzhemed TM 48 Cimzia TM 48 PRN FDA Approves 48 GeneChip miRNA 48 inhalation aerosol 48 Carotid 48 Non Mydriatic Digital 48 parenterally administered 48 PS# [001] 48 metabolic inhibitor 48 FDA Approvable Letter 48 MorphoSys proprietary 48 Neurotransmitter 48 Third Eye Retroscope 48 virulence genes 48 U#A [002] 48 optical biosensor 48 Zensana TM 48 Multistream 48 TaqMan 48 XP# XP# 48 fluticasone propionate FP 48 Gel Delivery 48 recombinant biopharmaceutical 48 MAXY VII 48 Apolipoprotein 48 Tamibarotene 48 Phase 2a trial 48 LEP ETU 48 Dural Regeneration Matrix 48 BLA submission 48 dimesylate 47 injectable formulation 47 miconazole Lauriad R 47 Z Foil 47 overactive bladder syndrome 47 initiate Phase 1b 47 qPCR assays 47 Chromera 47 Glucotrol XL 47 Loramyc 47 artus 47 octreotide acetate 47 Orphan Drug status 47 SN# [001] 47 pen injector 47 Sentrix 47 #.# MHz [002] 47 intravenous acetaminophen 47 Solorel 47 terlipressin 47 inhaled AAT 47 eFlow Technology 47 Fast Track Status 47 GeneChip R 47 oxybutynin gel